234
Views
3
CrossRef citations to date
0
Altmetric
Drug Profile

Elotuzumab: a novel immune-stimulating therapy to treat multiple myeloma

&
Pages 621-628 | Received 23 Feb 2016, Accepted 07 Jun 2016, Published online: 27 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Huihan Wang, Hua Shi, Xiaowei He & Aijun Liao. (2021) Downregulation of Chemokine CCL20 Involved in Myeloma Cells Resistant to Elotuzumab and Lenalidomide. OncoTargets and Therapy 14, pages 2789-2795.
Read now
Sebastian Grosicki, Martyna Bednarczyk & Grażyna Janikowska. (2020) Heat shock proteins as a new, promising target of multiple myeloma therapy. Expert Review of Hematology 13:2, pages 117-126.
Read now

Articles from other publishers (1)

Sebastian Grosicki, Martyna Bednarczyk, Agnieszka Barchnicka & Olga Grosicka. (2021) Elotuzumab in the treatment of relapsed and refractory multiple myeloma. Future Oncology 17:13, pages 1581-1591.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.